X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-and-pediatric-exclusivities-for-cresemba-isavuconazonium-sulfate-for-invasive-aspergillosis-and-invasive-mucormycosis-in-children-302084893.html
https://www.globenewswire.com//news-release/2024/03/11/2843460/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-milestone-payment-to-Basilea.html
https://www.globenewswire.com//news-release/2023/12/11/2793536/0/en/Basilea-announces-that-FDA-approves-expanded-use-of-antifungal-Cresemba-isavuconazole-in-the-United-States-in-children-with-invasive-aspergillosis-and-invasive-mucormycosis.html
https://www.prnewswire.com/news-releases/fda-approves-expanded-use-of-cresemba-isavuconazonium-sulfate-in-children-with-invasive-aspergillosis-and-invasive-mucormycosis-302010368.html
https://www.globenewswire.com/news-release/2023/11/20/2782909/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-third-sales-milestone-payment-for-the-region-from-Pfizer-this-year.html
https://www.prnewswire.com/news-releases/us-fda-accepts-astellas-snda-for-cresemba-isavuconazonium-sulfate-in-children-301897531.html
https://www.globenewswire.com/news-release/2023/06/08/2684411/0/en/Continued-strong-Cresemba-isavuconazole-sales-by-Pfizer-trigger-USD-26-million-sales-milestone-payments-to-Basilea.html
https://www.globenewswire.com/news-release/2023/02/07/2602601/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-second-sales-milestone-payment-to-Basilea-from-Pfizer.html
https://www.globenewswire.com/news-release/2023/01/09/2584783/0/en/Continued-strong-Cresemba-isavuconazole-sales-by-Astellas-in-the-U-S-trigger-CHF-20-million-sales-milestone-payment-to-Basilea.html
https://www.globenewswire.com//news-release/2022/12/23/2578974/0/en/Basilea-announces-regulatory-approval-of-antifungal-Cresemba-isavuconazole-in-Japan.html
https://www.globenewswire.com/news-release/2022/06/24/2468537/0/en/Basilea-announces-approval-for-additional-formulation-of-antifungal-Cresemba-isavuconazole-in-China.html
https://www.globenewswire.com/news-release/2022/06/17/2464429/0/en/Cresemba-sales-in-Asia-Pacific-region-trigger-sales-milestone-payment-to-Basilea-from-Pfizer.html
https://www.globenewswire.com/news-release/2022/01/13/2366066/0/en/Basilea-announces-approval-of-antifungal-Cresemba-isavuconazole-for-invasive-aspergillosis-in-China.html
https://www.biospace.com/article/releases/basilea-s-partner-asahi-kasei-pharma-filed-new-drug-application-for-the-marketing-authorization-of-isavuconazole-in-japan/?s=71
http://www.globenewswire.com/news-release/2020/08/07/2074832/0/en/Basilea-reports-acceptance-for-regulatory-review-of-Pfizer-s-marketing-authorization-application-for-antifungal-isavuconazole-Cresemba-in-China.html
http://www.globenewswire.com/news-release/2020/07/15/2062304/0/en/Basilea-reports-the-launch-of-antifungal-Cresemba-isavuconazole-in-Taiwan-triggering-the-second-milestone-payment-related-to-Asia-Pacific.html
https://www.globenewswire.com/news-release/2019/10/29/1936733/0/en/Basilea-reports-marketing-authorization-of-antifungal-Cresemba-in-Brazil.html
https://www.fiercebiotech.com/biotech/first-phase-3-data-back-scynexis-new-class-antifungal
http://press.pfizer.com/press-release/pfizer-enters-agreement-develop-and-commercialize-cresemba-isavuconazole-china-and-asi
http://press.pfizer.com/press-release/pfizer-completes-license-agreement-exclusive-commercialization-rights-europe-cresemba-
https://globenewswire.com/news-release/2017/07/20/1054486/0/en/Basilea-announces-completion-of-the-license-agreement-with-Pfizer-for-antifungal-Cresemba-for-Europe-Russia-Turkey-and-Israel.html
http://www.pharmatimes.com/Article/16-04-12/SMC_accepts_three_new_drugs_for_NHS_use_but_bans_two.aspx
http://www.prnewswire.com/news-releases/edison-issues-initiation-on-basilea-pharmaceutica-300241051.html
http://www.fiercebiotech.com/story/basilea-dumps-its-190m-ipo-plan-us-market-sputters/2015-12-09
Market Place
Share 
